The pattern and diagnostic criteria of sensory neuronopathy: a case-control study

Brain

Volumn 132, Issue 7, 2009, Pages 1723-1733

  Camdessanché, Jean Philippe ^a,b,c,d,e   Jousserand, Guillemette ^a,b   Ferraud, Karine ^a,b,c,d,e   Vial, Christophe ^a,f   Petiot, Philippe ^a,g   Honnorat, Jérôme ^e,f,h   Antoine, Jean Christophe ^a,b,d,e  

^a Centre de Référence Maladies Neuromusculaires Rares   (France)

^b UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

^c UNIVERSITÉ JEAN MONNET   (France)

^d Centre de Référence Maladies Rares Syndromes neurologiques paranéoplasiques   (France)

^e INSERM   (France)

^f HÔPITAL NEUROLOGIQUE   (France)

^g CROIX ROUSSE HOSPITAL   (France)

^h UNIVERSITÉ LYON 1   (France)

Author keywords

Cisplatin; Paraneoplastic neurological syndrome; Sensory ganglionopathy; Sensory neuronopathy; Sensory neuropathy

Indexed keywords

CISPLATIN;

ADULT; ARTICLE; ATAXIA; CASE CONTROL STUDY; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; HUMAN TISSUE; IDIOPATHIC DISEASE; MAJOR CLINICAL STUDY; MALE; PARANEOPLASTIC NEUROPATHY; PRIORITY JOURNAL; SENSORY NEURONOPATHY; SENSORY NEUROPATHY;

EID: 67650082478     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awp136     Document Type: Article

References (43)

1. Antoine JC, Mosnier JF, Honnorat J, Convers P, Absi L, Lapras J, et al. Paraneoplastic demyelinating neuropathy, subacute sensory neuropathy, and anti-Hu antibodies: clinicopathological study of an autopsy case. Muscle Nerve 1998; 21: 850-7.
2. Asbury AK. Sensory neuronopathy. Semin Neurol 1987; 7: 58-66.
3. Asbury AK, Brown MJ. Sensory neuronopathy and pure sensory neuropathy. Curr Opin Neurol Neurosurg 1990; 3: 708-11.
4. Brannagan TH 3rd, Hays AP, Chin SS, Sander HW, Chin RL, Magda P, et al. Small-fiber neuropathy/neuronopathy associated with celiac disease: skin biopsy findings. Arch Neurol 2005; 62: 1574-8.
5. Camdessanche JP, Antoine JC, Honnorat J, Vial C, Petiot P, Convers P, et al. Paraneoplastic peripheral neuropathy associated with anti-Hu antibodies. A clinical and electrophysiological study of 20 patients. Brain 2002; 125: 166-75.
6. Chai J, Herrmann DN, Stanton M, Barbano RL, Logigian EL. Painful small-fiber neuropathy in Sjogren syndrome. Neurology 2005; 65: 925-7.
7. Chalk CH, Windebank AJ, Kimmel DW, McManis PG. The distinctive clinical features of paraneoplastic sensory neuronopathy. Can J Neurol Sci 1992; 19: 346-51.
8. Colli BO, Carlotti CG Jr, Assirati JA Jr, Lopes Lda S, Marques W Jr, Chimelli L, et al. Dorsal root ganglionectomy for the diagnosis of sensory neuropathies. Surgical technique and results. Surg Neurol 2008; 69: 266-73; dicussion 273.
9. Dalakas MC. Chronic idiopathic ataxic neuropathy. Ann Neurol 1986; 19: 545-54.
10. Dalmau J, Furneaux HM, Rosenblum MK, Graus F, Posner JB. Detection of the anti-Hu antibody in specific regions of the nervous system and tumor from patients with paraneoplastic encephalomyelitis/sensory neuronopathy. Neurology 1991; 41: 1757-64.
11. Efron B. The jackknife, the bootstrap and other resampling plans. Philadelphia: Society for Industrial and Applied Mathematics; 1982.
12. Esiri MM, Morris CS, Millard PR. Sensory and sympathetic ganglia in HIV-1 infection: immunocytochemical demonstration of HIV-1 viral antigens, increased MHC class II antigen expression and mild reactive inflammation. J Neurol Sci 1993; 114: 178-87.
13. Gibbons CH, Vernino SA, Freeman R. Combined immunomodulatory therapy in autoimmune autonomic ganglionopathy. Arch Neurol 2008; 65: 213-7.
14. Gill JS, Windebank AJ. Cisplatin-induced apoptosis in rat dorsal root ganglion neurons is associated with attempted entry into the cell cycle. J Clin Invest 1998; 101: 2842-50.
15. Gorson KC, Herrmann DN, Thiagarajan R, Brannagan TH, Chin RL, Kinsella LJ, et al. Non-length dependent small fibre neuropathy/gang- lionopathy. J Neurol Neurosurg Psychiatry 2008; 79: 163-9.
16. Graus F, Delattre JY, Antoine JC, Dalmau J, Giometto B, Grisold W, et al. Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry 2004; 75: 1135-40.
17. Graus F, Keime-Guibert F, Rene R, Benyahia B, Ribalta T, Ascaso C, et al. Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients. Brain 2001; 124: 1138-48.
18. Graus F, Ribalta T, Campo E, Monforte R, Urbano A, Rozman C. Immunohistochemical analysis of the immune reaction in the nervous system in paraneoplastic encephalomyelitis. Neurology 1990; 40: 219-22.
19. Griffin JW, Cornblath DR, Alexander E, Campbell J, Low PA, Bird S, et al. Ataxic sensory neuropathy and dorsal root ganglionitis associated with Sjogren's syndrome. Ann Neurol 1990; 27: 304-15.
20. Hainfellner JA, Kristoferitsch W, Lassmann H, Bernheimer H, Neisser A, Drlicek M, et al. T-cell-mediated ganglionitis associated with acute sensory neuronopathy. Ann Neurol 1996; 39: 543-7.
21. Kishi M, Tanabe J, Schmelzer JD, Low PA. Morphometry of dorsal root ganglion in chronic experimental diabetic neuropathy. Diabetes 2002;51: 819-24.
22. Krarup-Hansen A, Helweg-Larsen S, Schmalbruch H, Rorth M, Krarup C. Neuronal involvement in cisplatin neuropathy: prospective clinical and neurophysiological studies. Brain 2007; 130: 1076-88.
23. Kuntzer T, Antoine JC, Steck AJ. Clinical features and pathophysiological basis of sensory neuronopathies (ganglionopathies). Muscle Nerve 2004; 30: 255-68.
24. Kurokawa K, Noda K, Mimori Y, Watanabe C, Katayama S, Nakamura S, et al. A case of pandysautonomia with associated sensory gangliono-pathy. J Neurol Neurosurg Psychiatry 1998; 65: 278-9.
25. Kusunoki S, Shimizu J, Chiba A, Ugawa Y, Hitoshi S, Kanazawa I. Experimental sensory neuropathy induced by sensitization with gang-lioside GD1b. Ann Neurol 1996; 39: 424-31.
26. Lauria G, Pareyson D, Grisoli M, Sghirlanzoni A. Clinical and magnetic resonance imaging findings in chronic sensory ganglionopathies. Ann Neurol 2000; 47: 104-9.
27. Lauria G, Pareyson D, Sghirlanzoni A. Neurophysiological diagnosis of acquired sensory ganglionopathies. Eur Neurol 2003; 50: 146-52.
28. Lauria G, Sghirlanzoni A, Lombardi R, Pareyson D. Epidermal nerve fiber density in sensory ganglionopathies: clinical and neurophysiologic correlations. Muscle Nerve 2001; 24: 1034-9.
29. Mori K, Iijima M, Koike H, Hattori N, Tanaka F, Watanabe H, et al. The wide spectrum of clinical manifestations in Sjogren. Brain 2005; 128:2518-34.
30. Mori K, Iijima M, Sugiura M, Koike H, Hattori N, Ito H, et al. Sjogren. J Neurol Neurosurg Psychiatry 2003; 74: 1320-2.
31. Okajima T, Yamamura S, Hamada K, Kawasaki S, Ideta T, Ueno H, et al. Chronic sensory and autonomic neuropathy. Neurology 1983; 33:1061-4.
32. Scaravilli F, Sinclair E, Arango JC, Manji H, Lucas S, Harrison MJ. The pathology of the posterior root ganglia in AIDS and its relationship to the pallor of the gracile tract. Acta Neuropathol 1992; 84: 163-70.
33. Sghirlanzoni A, Pareyson D, Lauria G. Sensory neuron diseases. Lancet Neurol 2005; 4: 349-61.
34. Sobue G, Yanagi T, Hashizume Y. Chronic progressive sensory ataxic neuropathy with polyclonal gammopathy and disseminated focal perivascular cellular infiltrations. Neurology 1988; 38: 463-7.
35. Sobue G, Yasuda T, Kachi T, Sakakibara T, Mitsuma T. Chronic progressive sensory ataxic neuropathy: clinicopathological features of idiopathic and Sjogren's syndrome-associated cases. J Neurol 1993;240: 1-7.
36. Sommer C, Lauria G. Skin biopsy in the management of peripheral neuropathy. Lancet Neurol 2007; 6: 632-42.
37. Thomas PK, Ochoa J. Symptomatology and differential diagnosis of peripheral neuropathy. In: PJ Dyck, PK Thomas, editors. Peripheral neuropathy. Vol. II. Philadelphia: Saunders, W.B. Company; 1993. p. 749-74.
38. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American- European Consensus Group. Ann Rheum Dis 2002; 61: 554-8.
39. Wanschitz J, Hainfellner JA, Kristoferitsch W, Drlicek M, Budka H. Ganglionitis in paraneoplastic subacute sensory neuronopathy: a morphologic study. Neurology 1997; 49: 1156-9.
40. Wasson JH, Sox HC, Neff RK, Goldman L. Clinical prediction rules. Applications and methodological standards. N Engl J Med 1985;313: 793-9.
41. Windebank AJ. Neurotoxicity of pyridoxine analogs is related to coenzyme structure. Neurochem Pathol 1985; 3: 159-67.
42. Windebank AJ, Blexrud MD, Dyck PJ, Daube JR, Karnes JL. The syndrome of acute sensory neuropathy: clinical features and electro- physiologic and pathologic changes. Neurology 1990; 40: 584-91.
43. Xu Y, Sladky JT, Brown MJ. Dose-dependent expression of neuronopathy after experimental pyridoxine intoxication. Neurology 1989; 39:1077-83.